Drug Trial Radar · NCT07503210
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
606
Actual
Start
Apr 21, 2026
Primary completion
Jun 6, 2028
Study completion Jul 4, 2028
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Mar 31, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
Conditions
- Obesity
Interventions
NNC0487-0111Drug
NNC0487-0111 will be administered subcutaneously.
Placebo (matched to NNC0487-0111)Drug
Placebo will be administered subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relative change in body weightTime frame: From week 40 to week 92
Locations
72 sites in 12 countries. Site status is shown where the registry gives one.
Pinnacle Research Group LLC
Anniston, Alabama
Diablo Clinical Research, Inc.
Walnut Creek, California
Florida Inst For Clin Res LLC
Orlando, Florida
Endeavor Health
Skokie, Illinois
Midwest Inst For Clin Res
Indianapolis, Indiana
Medication Mgmnt, LLC_Grnsboro
Greensboro, North Carolina
PMG Research of Wilmington LLC
Wilmington, North Carolina
UPA Ctr Weight and Eating Dis
Philadelphia, Pennsylvania
Clinical Res Collaborative
Cumberland, Rhode Island
North Texas Endocrine Center
Dallas, Texas
UT Southwestern Med Cntr
Dallas, Texas
Selma Medical Associates
Winchester, Virginia
Rainier Clin Res Ctr Inc
Renton, Washington
CIPREC Pueyrredon
Buenos Aires, Argentina
Conexa
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
CICEMO- Consultorio (Av Directorio)
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Instituto de Investigaciones Clinicas Mar Del Plata
Mar del Plata, Buenos Aires, Argentina
Sydney Clinical Trials
Campbelltown, New South Wales, Australia
Sydney Cardiometabolic Centre
Liverpool, New South Wales, Australia
Hunter Diabetes Centre
Merewether, New South Wales, Australia
Nightingale Research Adelaide
Adelaide, South Australia, Australia
Anima Research Center
Diepenbeek, Belgium
AZ Groeninge - Kortrijk - Centrum Endo - Diabetologie
Kortrijk, Belgium
Centre hospitalier universitaire de Liège (CHU de Liège)
Liège, Belgium
AZ OOSTENDE (Campus DAMIAAN)
Ostend, Belgium
DCC 1 - Lom EOOD
Lom, Bulgaria
MHAT Med Line Clinic
Plovdiv, Bulgaria
UMHAT Kaspela EOOD, Endocrinology and Metabolic Diseases Clinic
Plovdiv, Bulgaria
AIPSOMCEMD ENDO MED CONSULT 2020 - Dr. Aleksander Botushanov EOOD
Plovdiv, Bulgaria
SGHAT Dr. Shterev EOOD
Sofia, Bulgaria
UMHAT Aleksandrovska EAD, Clinic of Endocrinology and Metabolic Diseases
Sofia, Bulgaria
Medical Center Maraya Med EOOD
Sofia, Bulgaria
AIPSMC Dr. Traykovska EOOD
Sofia, Bulgaria
Sjællands Universitetshospital, Køge - Medicinsk Afdeling
Køge, Region Sjælland, Denmark
Sydvestjysk Sygehus Esbjerg - Medicinsk Endokrinologisk Ambulatorium, Forskningsenheden
Esbjerg, Region Syddanmark, Denmark
Sanos Clinic - Vejle
Vejle, Region Syddanmark, Denmark
CHU DE CLERMONT-FERRAND-HOPITAL GABRIEL MONTPIED_Service de Nutrition
Clermont-Ferrand, France
CHU GRENOBLE ALPES-SITE NORD MICHALLON_Endocrinologie,diabétologie,maladies de la nutrition
La Tronche, France
GROUPE SOS SANTE-HOPITAL LE CREUSOT-HOTEL DIEU_ Service de Diabétologie
Le Creusot, France
CHU LILLE-HOPITAL CLAUDE HURIEZ_Service de Chirurgie Générale et Endocrinienne
Lille, France
Showing 40 of 72 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.